Analyses reveal rs892145-T may protect against Parkinson's disease in African ancestry males, indicating genetic factors play a role in disease risk.
Variants in PGLYRP2 , particularly rs892145-T, have been suggested as Parkinson’s disease (PD) risk factors. We analyzed data from 31,334 PD patients and 17,772 controls across diverse ancestries. A significant sex-dependent effect of rs892145-T was observed in African (AFR) ancestry males (OR=0.73, 95%CI: 0.57-0.94, p=0.014). Gene-based analyses identified another variant, rs7251871-A, as significantly associated with PD in AFR males (OR=1.34, 95%CI:1.13-1.59, p=6.65E-04, Bonferroni p=0.0432). No associations were observed in other ancestries. Further studies are needed to understand PGLYRP2’s role in PD. Plain language summary (PLS) Genetic variations in the PGLYRP2 gene have been linked to the risk of developing Parkinson’s disease (PD), but the research reports have been inconclusive. In this study, we therefore investigated whether genetic variants in this gene are associated with PD. We analyzed data from 32,334 people with PD and 17,772 people without the disease, all from diverse ancestral backgrounds. We found that a previously reported genetic variant, called rs892145-T, appeared to have a possible protective effect against PD specifically in males of African descent. We also identified a different variant, rs7251871-A, which had not been linked to PD before, that seemed to increase PD risk in the same group. No significant results were found in other ancestry groups or for the females group. These findings need to be confirmed in future studies with larger numbers of participants to better understand the role of the gene PGLYRP2 in PD.
No takes yet. Share an insight, caveat, or question.
Ávila et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: